Bluejay Diagnostics, Inc. (NASDAQ:BJDX – Get Free Report) was up 1.3% during trading on Monday . The stock traded as high as $1.70 and last traded at $1.61. Approximately 125,806 shares were traded during trading, a decline of 81% from the average daily volume of 662,376 shares. The stock had previously closed at $1.59.
Bluejay Diagnostics Stock Up 1.3%
The stock has a market cap of $2.41 million, a price-to-earnings ratio of 0.00 and a beta of 0.47. The company has a 50 day simple moving average of $1.72 and a 200 day simple moving average of $2.87.
Bluejay Diagnostics (NASDAQ:BJDX – Get Free Report) last issued its quarterly earnings data on Tuesday, May 13th. The company reported ($3.37) earnings per share (EPS) for the quarter.
Bluejay Diagnostics Company Profile
Bluejay Diagnostics, Inc, a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components.
Featured Articles
- Five stocks we like better than Bluejay Diagnostics
- How Can Investors Benefit From After-Hours Trading
- These 3 Undervalued Stocks Could Surge as Value Rotation Nears
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Tilray Shares Blazing: What’s Behind the 55% Rally This Month?
- Insider Trades May Not Tell You What You Think
- 3 Retail Stocks to Watch as Back-to-School Spending Ramps Up
Receive News & Ratings for Bluejay Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bluejay Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
